malondialdehyde has been researched along with natriuretic peptide, c-type in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, X; Li, X; Xu, D; Zhang, J; Zhang, Y | 1 |
1 other study(ies) available for malondialdehyde and natriuretic peptide, c-type
| Article | Year |
|---|---|
C-type natriuretic peptide ameliorates ischemia/reperfusion-induced acute kidney injury by inhibiting apoptosis and oxidative stress in rats.
Topics: Acute Kidney Injury; Animals; Apoptosis; bcl-2-Associated X Protein; Blood Urea Nitrogen; Blotting, Western; Creatinine; Cyclic GMP; In Situ Nick-End Labeling; Male; Malondialdehyde; Natriuretic Peptide, C-Type; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Receptors, Atrial Natriuretic Factor; Reperfusion Injury; Signal Transduction; Superoxide Dismutase | 2014 |